Roman Urfer

Title: Roman Urfer: Innovator in Neurotrophic Factors

Introduction

Roman Urfer is a distinguished inventor based in Pacifica, CA (US). He has made significant contributions to the field of neurotrophic factors, holding a total of 15 patents. His work focuses on developing innovative treatment methods for neuronal disorders.

Latest Patents

Among his latest patents are groundbreaking treatments using NGF variants. These NGF variants exhibit trkC-binding activity and trkC-signal inducing activity, which are crucial for addressing neuronal disorders. Additionally, these variants may also possess trkA or trkB binding and signal induction activity. Roman's inventions include nucleic acids and expression vectors that encode these NGF variant neurotrophins. Another notable patent involves pantropic neurotrophic factors, which demonstrate multiple neurotrophic specificities. These factors are also aimed at treating neuronal disorders and come with nucleic acids and expression vectors that encode the pantropic neurotrophins.

Career Highlights

Roman Urfer is currently associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to push the boundaries of neurotrophic research and contribute to advancements in treatment methodologies.

Collaborations

Throughout his career, Roman has collaborated with notable colleagues, including Leonard G Presta and John William Winslow. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Roman Urfer's contributions to neurotrophic factors and treatment methods for neuronal disorders highlight his role as a key innovator in the field. His ongoing work continues to pave the way for advancements in medical treatments.